EBV and nasopharyngeal carcinoma

[Analysis of application scope and current state survey of the reporting guideline for large language models in healthcare research (TRIPOD-LLM)].

Zhonghua yi xue za zhi·2025

Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas.

Molecular therapy oncolytics·2021

[Application of "Internet +" technology in maternal and child health management and service of district at provincial level].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2020

[Breastfeeding promotion strategies study on preterm infants in the neonatal intensive care unit].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2019

Tunneling anisotropic magnetoresistance driven by magnetic phase transition.

Nature communications·2017

Involvement of mitochondrial aerobic respiratory activity in efflux-mediated resistance of C. albicans to fluconazole.

Journal de mycologie medicale·2017

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Investigating POLG-driven modulation of cancer stemness: a pilot study in breast cancer cells.

Aging·2026

The molecular landscape of chordoma: Current frontiers from multi-omics to artificial intelligence.

Biochimica et biophysica acta. Reviews on cancer·2026

A Data-Driven Atlas of CAR-Based Immunotherapy in Lung Cancer: Insights from Multidatabase Integration.

Pharmacological research·2026

Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1α-SIX1 axis.

iScience·2026

Insulin Resistance and Cutaneous Squamous Cell Carcinoma: A Narrative Review of Molecular Mechanisms.

Iranian journal of medical sciences·2026

Cardiovascular Diseases and Cancer: Convergent Proteostasis Networks at the Crossroads of Mechanisms and Therapeutic Opportunities.

MedComm·2026

Related Experiment Videos

EBV and nasopharyngeal carcinoma

Related Concept Videos

[Analysis of application scope and current state survey of the reporting guideline for large language models in healthcare research (TRIPOD-LLM)].

Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas.

[Application of "Internet +" technology in maternal and child health management and service of district at provincial level].

[Breastfeeding promotion strategies study on preterm infants in the neonatal intensive care unit].

Tunneling anisotropic magnetoresistance driven by magnetic phase transition.

Involvement of mitochondrial aerobic respiratory activity in efflux-mediated resistance of C. albicans to fluconazole.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Investigating POLG-driven modulation of cancer stemness: a pilot study in breast cancer cells.

The molecular landscape of chordoma: Current frontiers from multi-omics to artificial intelligence.

A Data-Driven Atlas of CAR-Based Immunotherapy in Lung Cancer: Insights from Multidatabase Integration.

Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1α-SIX1 axis.

Insulin Resistance and Cutaneous Squamous Cell Carcinoma: A Narrative Review of Molecular Mechanisms.

Cardiovascular Diseases and Cancer: Convergent Proteostasis Networks at the Crossroads of Mechanisms and Therapeutic Opportunities.

Related Experiment Videos

EBV and nasopharyngeal carcinoma

Related Concept Videos

Related Articles